US

Digital health firms Neurotrack procures $21 mln Series C

Redwood City, California-based Neurotrack, a digital health company, has secured $21 million in Series C funding. Khosla Ventures led the round.

Edgewise Networks locks in $11 mln

Burlington, Massachusetts-based Edgewise Networks, a microsegmentation platform based on software identity, has secured $11 million in funding. The lead investors were.406 Ventures and Accomplice. Also, Pillar participated in the round.

Alyce nets $11.5 mln Series A

Boston-based Alyce Inc, an AI-powered platform that’s redefining direct mail and swag, has raised $11.5 million in Series A funding. Manifest led the round with participation from General Catalyst, Boston Seed Capital, Golden Ventures, Morningside and Victress Capital.

Oncologie takes in $80 mln Series B

Boston and Shanghai-based Oncologie, an biopharmaceutical company, has secured $80 million in Series B financing. Nan Fung Life Sciences and Pivotal BioVentures China led the round.

Aquabyte picks up $10 mln Series A

San Francisco and Norway-based Aquabyte, an aquaculture startup, has raised $10 million in Series A funding. Costanoa Ventures and New Enterprise Associates Inc led the round with participation from other investors that included Alaya Capital Partners, Alliance Venture and Struck Capital.

Fireblocks snags $16 mln Series A

New York City and Tel Aviv-based Fireblocks, an enterprise platform for securing digital assets in transit, has raised $16 million in Series A funding. The investors were Cyberstarts, Tenaya Capital, Eight Roads, Swisscom Ventures and MState.

Genome Medical attracts $23 mln Series B

South San Francisco-based Genome Medical, a telegenomics company, has raised $23 million in Series B funding. Echo Health Ventures led the round.

Tenderd lands $5.8 mln seed

Tenderd, a heavy equipment rental marketplace, has secured $5.8 million in seed funding. The lead investors were Y Combinator and BECO.

VC-backed CloudBees acquires Rollout

CloudBees has acquired Rollout, a provider of software for developers and product teams. No financial terms were disclosed. CloudBees is backed by Matrix Partners, Lightspeed Venture Partners, Verizon Ventures, Delta-v Capital, Golub Capital and Unusual Ventures.

VC-backed ReViral appoints CEO

ReViral Ltd, a developer of novel, antiviral compounds that target respiratory syncytial virus, has named Alex C. Sapir as CEO. Sapir is the former president and CEO of Dova Pharmaceuticals. ReViral is backed by New Leaf Venture Partners, Novo Ventures, Perceptive Advisors, Andera Partners, OrbiMed and Brace Pharma Capital.